Fidelity Select Portfolios. Holdings as of May 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| ELI LILLY and COLLY | 28.78% | $431.84M | 390,801 |
| GSK PLCGSK | 8.17% | $122.57M | 2,425,160 |
| UCB SA | 5.09% | $89.07M | 260,100 |
| ROCHE HOLDING AG | 4.54% | $87.36M | 161,630 |
| VIATRIS INCVTRS | 5.45% | $81.83M | 5,032,300 |
| MERCK and CO INCMRK | 4.74% | $71.15M | 599,336 |
| LEGEND BIOTECH CORPLEGN | 4.53% | $68.02M | 2,504,500 |
| ASTRAZENECA PLC | 4.22% | $63.38M | 341,350 |
| ELANCO ANIMAL HEALTH INCELAN | 4.15% | $62.27M | 2,611,000 |
| JAZZ PHARMACEUTICALS PLC | 4.09% | $61.39M | 259,600 |
| GILEAD SCIENCES INCGILD | 3.97% | $59.53M | 442,800 |
| JOHNSON and JOHNSONJNJ | 3.77% | $56.60M | 251,200 |
| ROYALTY PHARMA PLC | 2.67% | $40.09M | 718,900 |
| Fidelity Revere Street TrustCash or money market | 2.44% | $36.65M | 36,651,092 |
| MODERNA INCMRNA | 1.57% | $23.56M | 499,200 |
| INTELLIA THERAPEUTICS INCNTLA | 1.19% | $17.82M | 1,266,200 |
| BEAM THERAPEUTICS INCBEAM | 1.10% | $16.48M | 500,600 |
| AXSOME THERAPEUTICS INCAXSM | 1.08% | $16.18M | 69,000 |
| BIONTECH SEBNTX | 1.04% | $15.66M | 163,253 |
| XENON PHARMACEUTICALS INCXENE | 0.82% | $12.37M | 226,000 |
| OCULAR THERAPEUTIX INCOCUL | 0.80% | $12.00M | 1,331,717 |
| IDEXX LABORATORIES INCIDXX | 0.61% | $9.13M | 16,200 |
| PTC THERAPEUTICS INCPTCT | 0.54% | $8.12M | 110,000 |
| CAPRICOR THERAPEUTICS INCCAPR | 0.46% | $6.93M | 231,300 |
| KYMERA THERAPEUTICS INCKYMR | 0.46% | $6.88M | 84,500 |
| ANNEXON INCANNX | 0.36% | $5.44M | 1,003,800 |
| ARROWHEAD PHARMACEUTICALS INCARWR | 0.34% | $5.10M | 65,400 |
| HARMONY BIOSCIENCES HOLDINGS INCHRMY | 0.33% | $5.01M | 158,577 |
| SERIF BIOMEDICINES, INCPreferred | 0.33% | $5.00M | 1,886,792 |
| CRINETICS PHARMACEUTICALS INC | 0.31% | $4.67M | 131,498 |
| DEFINIUM THERAPEUTICS INCDFTX | 0.30% | $4.55M | 188,000 |
| AGOMAB THERAPEUTICS SA | 0.25% | $4.37M | 332,858 |
| CORCEPT THERAPEUTICS INCCORT | 0.29% | $4.33M | 62,300 |
| UNIQURE N.V. | 0.28% | $4.20M | 147,178 |
| ASCENDIS PHARMA A/S | 0.27% | $4.10M | 18,300 |
| DISC MEDICINE INCIRON | 0.25% | $3.74M | 53,800 |
| AMYLYX PHARMACEUTICALS INCAMLX | 0.25% | $3.70M | 257,800 |
| PHIBRO ANIMAL HEALTH CORPPAHC | 0.20% | $3.07M | 99,800 |
| IONIS PHARMACEUTICALS INCIONS | 0.20% | $3.07M | 40,100 |
| EDGEWISE THERAPEUTICS INCEWTX | 0.19% | $2.86M | 83,600 |
| Fidelity Revere Street TrustCash or money market | 0.17% | $2.59M | 2,589,273 |
| PARAGON BIOSCIENCES EMALEX CAPITAL INCPreferred | 0.15% | $2.20M | 158,879 |
| CASTLE CREEK BIOSCIENCES INCPreferred | 0.09% | $1.41M | 6,308 |
| RAIA DROGASIL SA | 0.42% | $1.24M | 1,691,900 |
| EVOZYNE INCBond | 0.08% | $1.22M | 1,026,017 |
| EVOZYNE INCPreferred | 0.06% | $948.20K | 56,643 |
| SWEDISH ORPHAN BIOVITRUM AB | 0.54% | $882.84K | 170,200 |
| PARAGON BIOSCIENCES EMALEX CAPITAL INCPreferred | 0.02% | $310.86K | 22,477 |
| PARAGON BIOSCIENCES EMALEX CAPITAL INCPreferred | 0.01% | $220.96K | 15,977 |
| KAILERA THERAPEUTICS INCKLRA | 0.01% | $206.46K | 9,000 |